Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trafermin spray for diabetic foot ulcer (TRANS-South)
NCT01217463Phase 3Completed
- Sponsor
- Olympus Biotech
- Start
- Nov 2010
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of trafermin in diabetic foot ulcer (DFU), sponsored by Olympus Biotech. Started Nov 2010; status: completed.
02
Drugs
trafermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT01217463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01217463.